drugset / Trial / NCT04082481
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-988 in Healthy Participants
RandomizedSequentialDouble-blindOther
Summary
The purpose of this study is to assess the safety and tolerability of TAK-988 following single and multiple oral doses in healthy non-Japanese and Japanese adult participants and healthy elderly (HE) participants.
Timeline
- Start
- 2021-11-17
- Primary completion
- 2022-04-29
- Completion
- 2022-04-29
Outcome
Outcome not reported
Stopped (Enrollment): “The study stopped early, before enrolling its first participant.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TAK-988 | Unknown | — | Oral |
Indications
No indication recorded.